QUALLENT PHARMACEUTICALS Trademark

Trademark Overview


On Wednesday, April 7, 2021, a trademark application was filed for QUALLENT PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the QUALLENT PHARMACEUTICALS trademark a serial number of 90628728. The federal status of this trademark filing is REGISTERED as of Tuesday, March 7, 2023. This trademark is owned by Express Scripts Strategic Development, Inc.. The QUALLENT PHARMACEUTICALS trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

Pharmaceutical preparations for use in treating human diseases, namely, the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutraceuticals for use as human dietary supplements; and health food supplements for use in treating human dietary deficiencies

Wholesale distributorship services featuring pharmaceutical preparations for use in treating human diseases
quallent pharmaceuticals

General Information


Serial Number90628728
Word MarkQUALLENT PHARMACEUTICALS
Filing DateWednesday, April 7, 2021
Status700 - REGISTERED
Status DateTuesday, March 7, 2023
Registration Number6997500
Registration DateTuesday, March 7, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in treating human diseases, namely, the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutraceuticals for use as human dietary supplements; and health food supplements for use in treating human dietary deficiencies
Goods and ServicesWholesale distributorship services featuring pharmaceutical preparations for use in treating human diseases
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 14, 2021
Primary Code005
First Use Anywhere DateMonday, November 15, 2021
First Use In Commerce DateMonday, November 15, 2021

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, July 14, 2021
Primary Code035
First Use Anywhere DateMonday, November 15, 2021
First Use In Commerce DateMonday, November 15, 2021

Trademark Owner History


Party NameExpress Scripts Strategic Development, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63121

Party NameExpress Scripts Strategic Development, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63121

Party NameExpress Scripts Strategic Development, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63121

Trademark Events


Event DateEvent Description
Tuesday, March 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 7, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, February 2, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 1, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 19, 2023TEAS EXTENSION RECEIVED
Thursday, January 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 15, 2022USE AMENDMENT FILED
Thursday, January 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 15, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 15, 2021NON-FINAL ACTION E-MAILED
Monday, November 15, 2021NON-FINAL ACTION WRITTEN
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Wednesday, July 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 10, 2021NEW APPLICATION ENTERED